Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13
Published May 1, 2024 · Recall initiated: April 9, 2024
Summary
FDA records drug Class III recall D-0466-2024, published May 1, 2024 and initiated April 9, 2024. Recalling firm: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.; Status: Ongoing; Reported quantity: 108,192/30 count bottles or 7 count blister packs; Lot: Lot # AKS00623A, Exp 01/31/2026; AKS00322A, Exp 02/28/2025. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Products
What to do
Voluntary: Firm initiated · Letter
Get an email if ABILIFY has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ABILIFY
- Manufacturer
- Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- Distributor
- USA nationwide.
- Lot
- Lot # AKS00623A, Exp 01/31/2026; AKS00322A, Exp 02/28/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- Japan
Related recalls
- FDAAbilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical,May 1, 2024
- FDAAbilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 countMay 1, 2024
- FDAAbilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical,May 1, 2024
- FDAFUL-GLO, Fluorescein Sodium Ophthalmic Strips USP 1 mg, 100 sterile strips per carton, Manufactured for:May 1, 2024
- FDAFUL-GLO, Fluorescein Sodium Sterile Ophthalmic Strips USP (0.6 mg Fluorescein), 300 sterile strips per carton,May 1, 2024
- FDAABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America PharmaceuticalMarch 13, 2013
Questions about this recall
Was Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13 recalled?
Yes. FDA published recall D-0466-2024 on May 1, 2024. Reported hazard: Cross Contamination with Other Products
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ABILIFY.